GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » YoY EBITDA Growth

Hexima (ASX:HXL) YoY EBITDA Growth : 77.78% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Hexima YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Hexima's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 77.78%.

Hexima's EBITDA per Share for the six months ended in Dec. 2023 was A$-0.00.


Hexima YoY EBITDA Growth Historical Data

The historical data trend for Hexima's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima YoY EBITDA Growth Chart

Hexima Annual Data
Trend Jun08 Jun09 Jun10 Jun20 Jun21 Jun22 Jun23
YoY EBITDA Growth
Get a 7-Day Free Trial 43.17 100.00 - -8.47 82.81

Hexima Semi-Annual Data
Dec06 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.69 -9.38 67.86 94.29 77.78

Hexima YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Hexima's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (A: Jun. 2023 )
=(EBITDA per Share (A: Jun. 2023 )-EBITDA per Share (A: Jun. 2022 ))/ | EBITDA per Share (A: Jun. 2022 ) |
=(-0.011--0.064)/ | -0.064 |
=82.81 %

Hexima's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.002--0.009)/ | -0.009 |
=77.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hexima YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Hexima's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Hexima (ASX:HXL) Business Description

Traded in Other Exchanges
N/A
Address
84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Hexima (ASX:HXL) Headlines

From GuruFocus

Hexcel Reports 2023 Third Quarter Results

By Business Wire 10-23-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 01-26-2022

Hexcel Declares Quarterly Dividend

By Business Wire 07-24-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 07-25-2022

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 04-24-2023